Not applicableNot Yet RecruitingNCT06902025What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaWho this might be right forB-ALL He Huang 24
Early research (Phase 1)Study completedNCT02529813What this trial is testingCD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01466179What this trial is testingClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 225
Post-approval studies (Phase 4)Study completedNCT03677596What this trial is testingTwo Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsWho this might be right forLeukemiaPrecursor b-Cell Lymphoblastic Leukemia-LymphomaACUTE LYMPHOBLASTIC LEUKEMIA Pfizer 102
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625What this trial is testingInvestigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome National Cancer Institute (NCI) 6,720
Not applicableLooking for participantsNCT06649253What this trial is testingChildhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in RelapseWho this might be right forLeukemia, Lymphoblastic, Acute, Pediatric Rennes University Hospital 50
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Early research (Phase 1)Temporarily pausedNCT00077493What this trial is testingBL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma MedImmune LLC 95
Very early researchLooking for participantsNCT04512716What this trial is testingIomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaWho this might be right forB-ALLDLBCLB ALL+8 more Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00241358What this trial is testingStudy Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more Washington University School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT01258998What this trial is testingStudy of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more National Cancer Institute (NCI) 60
Very early researchUnknownNCT04626726What this trial is testingAdult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forAdult B Acute Lymphoblastic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 50
Very early researchUnknownNCT05747157What this trial is testingSafety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical ResearchWho this might be right forB-cell Acute Lymphoblastic Leukemia Anhui Provincial Hospital 18
Early research (Phase 1)Study completedNCT00054236What this trial is testingCombination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 55
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Post-approval studies (Phase 4)Ended earlyNCT02618109What this trial is testingIdentification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaLeukemia Relapse University Hospital, Angers 119
Not applicableNot Yet RecruitingNCT07499336What this trial is testingUNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST PEG ASPARAGINASEWho this might be right forAcute Lymphoblastic Leukaemia - Category Aarhus University Hospital 45
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01219816What this trial is testingMulti-centric StudyWho this might be right forB ALLCD22+ ExpressionRefractory B-ALL Nantes University Hospital 57